May 12, 2015 7:50 am EDT VolitionRx Announces First Quarter 2015 Financial Results and Business Update
May 8, 2015 8:00 am EDT VolitionRx Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating NuQ® Assays in Most Prevalent Cancers
May 6, 2015 8:00 am EDT VolitionRx Schedules First Quarter 2015 Earnings Conference Call and Business Update for Tuesday, May 12, 2015 at 8:30 a.m. ET
Apr 21, 2015 8:00 am EDT VolitionRx Initiates Study with Hvidovre Hospital, Denmark, Specifically to Target NuQ(R) Biomarker Panel for Colorectal Polyps
Apr 9, 2015 8:00 am EDT VolitionRx Adds Three New Laboratory Automation Systems to Expedite Sample Analysis for its Large Ongoing Clinical Trials
Mar 5, 2015 8:00 am EST VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology
Feb 17, 2015 8:00 am EST VolitionRx Limited Announces Exercise of Over-Allotment Option in Previously Announced Public Offering
